Drug intelligence / Profile preview

monotropitoside

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Monotropitoside, also known as gaultherin, is a natural salicylate glycoside found in various plant species, including *Gaultheria yunnanensis* and *Filipendula ulmaria* (meadowsweet). It acts as a prodrug that is metabolically converted into salicylate, the active component responsible for its analgesic and anti-inflammatory effects. Preclinical studies have demonstrated its efficacy in animal models of rheumatoid arthritis, pain, and swelling, showing a potency comparable to aspirin but without the associated gastric ulcerogenic side effects. While it is a significant component of certain herbal remedies and has been investigated for its potential as a safer alternative to traditional non-steroidal anti-inflammatory drugs (NSAIDs), it remains primarily a research compound and is not currently marketed as a standalone pharmaceutical product.

Other names
gaultherinmethyl salicylate 2-O-beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on monotropitoside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on monotropitoside.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call